BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  EUROBIO SCIENTIFIC : 2025 ANNUAL RESULTS

  April 12, 2026

   · 

  8 min read
• Press Releases

  FairJourney Bio Opens Cryo-EM Structural Biology Facility in San Diego

  April 12, 2026

   · 

  3 min read
• Press Releases

  Miracell Receives FDA 510(k) Clearance for SMART M-CELL PRP Concentration System and SMART M-CELL Bone Marrow Concentration System

  April 12, 2026

   · 

  4 min read
• Press Releases

  Apotex Receives First U.S. FDA Tentative Approval for a Generic Version of Ozempic® (Semaglutide Injection) in Partnership with Orbicular

  April 12, 2026

   · 

  2 min read
• Press Releases

  Pendulum Therapeutics Expands Clinical Collaboration to Advance Microbiome Research in Women’s Health and Dermatology

  April 12, 2026

   · 

  2 min read
• Press Releases

  Government of Canada announces additional investment to support the Canadian Critical Drug Initiative

  April 12, 2026

   · 

  4 min read
• Press Releases

  IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference

  April 12, 2026

   · 

  2 min read
• Press Releases

  Allogene Therapeutics to Announce Interim Futility Analysis Data from its Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation LBCL on Monday, April 13, 2026

  April 12, 2026

   · 

  1 min read
• Press Releases

  Spyre Therapeutics to Host Conference Call to Report SPY001 Part A Induction Topline Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients on April 13, 2026

  April 12, 2026

   · 

  1 min read
• Press Releases

  IDEAYA Biosciences to Announce Topline Results from Phase 2/3 OptimUM-02 Trial in Metastatic Uveal Melanoma on Monday, April 13, 2026

  April 12, 2026

   · 

  1 min read